CP
LLY icon

Camelot Portfolios’s Eli Lilly LLY Stock Holding History

Camelot Portfolios’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$734K Buy
+612
New +$625K 0.51% 67
2026
Q1 		– Sell
-21
Closed -$22.6K – 379
2025
Q4 		$22.6K Buy
+21
New +$20.1K 0.01% 367
2025
Q2 		– Sell
-880
Closed -$726K – 212
2025
Q1 		$726K Buy
+880
New +$732K 0.45% 83
2024
Q3 		– Sell
-1,775
Closed -$1.61M – 368
2024
Q2 		$1.61M Buy
+1,775
New +$1.42M 0.91% 24
2024
Q1 		– Sell
-1,492
Closed -$870K – 175
2023
Q4 		$870K Buy
+1,492
New +$871K 0.51% 65
2022
Q1 		– Sell
-2,200
Closed -$608K – 248
2021
Q4 		$608K Buy
+2,200
New +$558K 0.24% 131
2021
Q3 		– Sell
-2,200
Closed -$505K – 238
2021
Q2 		$505K Sell
2,200
-35
-2% -$7.03K 0.2% 136
2021
Q1 		$418K Buy
+2,235
New +$437K 0.17% 148
2020
Q3 		– Sell
-2,701
Closed -$444K – 207
2020
Q2 		$444K Sell
2,701
-201
-7% -$30.9K 0.29% 99
2020
Q1 		$403K Buy
2,902
+2
+0.1% +$275 0.22% 117
2019
Q4 		$381K Buy
2,900
+1
+0% +$116 0.16% 146
2019
Q3 		$324K Hold
2,899
– – 0.15% 153
2019
Q2 		$321K Hold
2,899
– – 0.13% 168
2019
Q1 		$376K Hold
2,899
– – 0.16% 155
2018
Q4 		$335K Hold
2,899
– – 0.16% 144
2018
Q3 		$311K Hold
2,899
– – 0.14% 159
2018
Q2 		$247K Hold
2,899
– – 0.11% 178
2018
Q1 		$224K Hold
2,899
– – 0.1% 167
2017
Q4 		$245K Hold
2,899
– – 0.12% 150
2017
Q3 		$248K Hold
2,899
– – 0.12% 144
2017
Q2 		$239K Hold
2,899
– – 0.12% 148
2017
Q1 		$244K Sell
2,899
-5,600
-66% -$449K 0.12% 152
2016
Q4 		$625K Buy
+8,499
New +$633K 0.33% 87

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Camelot Portfolios's LLY Position: Q2 2026 in Review

Camelot Portfolios opened a new position in Eli Lilly (LLY) in Q2 2026: 612 shares worth $734K. The stake represents 0.51% of the portfolio and ranks #67 among its holdings. This is a return to the name: Camelot Portfolios previously reported a position in LLY as recently as Q4 2025.

Camelot Portfolios first reported a position in LLY in Q4 2016 and has held it in 23 quarters since. The position peaked at $1.61M in Q2 2024. 4,593 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Camelot Portfolios held 612 shares of Eli Lilly worth $734K as of Q2 2026.
  • Eli Lilly was a new Camelot Portfolios position in Q2 2026.
  • Eli Lilly made up 0.51% of Camelot Portfolios's portfolio in Q2 2026, its #67 holding.
  • Camelot Portfolios first reported a position in Eli Lilly in Q4 2016 and has held it in 23 quarters since.
  • Camelot Portfolios's Eli Lilly position peaked at $1.61M in Q2 2024.
  • 4,593 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Camelot Portfolios's 13F filing for Q2 2026, filed 17 Jul 2026.